share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Garber Alan M

SEC announcement ·  May 3 16:18
Summary by Moomoo AI
Alan M Garber, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on May 1, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not specify Garber's relationship to the issuer or the status of the action, whether it was a purchase or sale. Investors are advised to seek additional information to fully understand the impact of this transaction on their investment decisions.
Alan M Garber, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on May 1, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not specify Garber's relationship to the issuer or the status of the action, whether it was a purchase or sale. Investors are advised to seek additional information to fully understand the impact of this transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more